Icosavax, Inc.Employment Agreement • August 14th, 2023 • Icosavax, Inc. • Biological products, (no disgnostic substances)
Icosavax, Inc. (the “Company”) is pleased to offer you (the “Employee”) a position on the terms set forth in this letter (this “Agreement”). In consideration of the mutual promises herein contained, the parties agree as follows:
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. PUBLIC HEALTH SERVICE Amendment This Agreement is based...Amendment • August 14th, 2023 • Icosavax, Inc. • Biological products, (no disgnostic substances)
This is the Third amendment ("Third Amendment") of the agreement by and between the NIAID and Licensee having an effective date of June 28, 2018 and having NIAID Reference Number [***], as amended by the First amendment dated September 10, 2018 and having NIAID Reference Number [***] (the "First Amendment") and the Second amendment dated September 9, 2020 and having NIAID Reference Number [***] (the "Second Amendment") ( the "Agreement"). This Third Amendment, having NIAID Reference Number [***] includes, in addition to the amendments made below, a Signature Page.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT BETWEEN...Exclusive License Agreement • August 14th, 2023 • Icosavax, Inc. • Biological products, (no disgnostic substances) • Washington
This Amended and Restated Exclusive License Agreement [***] (this “Agreement”), effective as of the date of last signature (the “Effective Date”), is made and entered into between the University of Washington, a public institution of higher education and an agency of the state of Washington, (“University”), and Icosavax, Inc., a for profit corporation under the laws of Delaware (“Company”).
